Skip to contentA
Axogen, Inc.
A
AXGNAxogen, Inc. Q3 2020 · 10-Q
Revenue$33.43M$33.43M+17.0% vs Q3 2019 Net Income-$1.48M-$1.48MN/M vs Q3 2019 EPS Diluted-$0.04-$0.04N/M vs Q3 2019 Gross Profit$27,731,000+15.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,618,000N/M Free Cash Flowderived-$3,106,000N/M Margins · derivedGross margin83.0%−1.3 pt vs Q3 2019
Operating margin-3.1%+18.3 pt vs Q3 2019
Net margin-4.4%+15.1 pt vs Q3 2019
ended Sep 30, 2020 · filed Oct 30, 2020 · 30 d after period end